Increasing the reach: optimizing screening for atrial fibrillation—the STROKESTOP III study
The STROKESTOP III study will provide valuable information on which screening method to use for improved participation in atrial fibrillation screening.
Authors
- Fredrik Carlstedt
- Sofia Skröder (ORCID: https://orcid.org/0000-0002-6360-1167)
- Michael Ingre (ORCID: https://orcid.org/0000-0003-0678-4494)
- Mashroor Khan (ORCID: https://orcid.org/0000-0003-1615-5173)
- Anders Eriksson (ORCID: https://orcid.org/0000-0003-3436-3726)
- Mårten Rosenqvist (ORCID: https://orcid.org/0000-0003-3337-9259)
- Emma Svennberg (ORCID: https://orcid.org/0000-0002-6413-0870)
- Johanna Star Tenn
Institutions
- Karolinska University Hospital (SE)
- Örebro University (SE)
- Danderyds sjukhus (SE)
- Swedish Civil Contingencies Agency (SE)
- Karolinska Institutet (SE)
- Glanrhyd Hospital (GB)
- Center for Clinical Research Dalarna (SE)
- Region Värmland Kommunalförbund (SE)
Publication Details
- Journal
- EP Europace
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1093/europace/euae234
- Citations
- 4
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Hjärt-Lungfonden
- Vetenskapsrådet
- Stockholm läns landsting
- Center for Innovative Medicine